Magalasin, Rolando B.

HRN: 24-66-67  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/07/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/07/2024
03/14/2024
IV
600mg
Every 6 Hours
Carbuncle Upper Back Secondary To Uncontrolled DM
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: